UBS AM’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-140,675
| Closed | -$44.5M | – | 2579 |
|
|
2023
Q4 | $44.5M | Sell |
140,675
-17,189
| -11% | -$5.44M | 0.02% | 619 |
|
|
2023
Q3 | $26.7M | Buy |
157,864
+20,886
| +15% | +$3.53M | 0.01% | 705 |
|
|
2023
Q2 | $24.9M | Hold |
136,978
| – | – | 0.01% | 719 |
|
|
2023
Q1 | $24.9M | Buy |
136,978
+28,166
| +26% | +$5.12M | 0.01% | 719 |
|
|
2022
Q4 | $21.4M | Buy |
108,812
+3,259
| +3% | +$640K | 0.01% | 739 |
|
|
2022
Q3 | $23.7M | Sell |
105,553
-59,156
| -36% | -$13.3M | 0.01% | 722 |
|
|
2022
Q2 | $20.8M | Sell |
164,709
-78,517
| -32% | -$9.93M | 0.01% | 727 |
|
|
2022
Q1 | $30.8M | Buy |
243,226
+2,783
| +1% | +$353K | 0.01% | 728 |
|
|
2021
Q4 | $31.5M | Buy |
240,443
+23,880
| +11% | +$3.13M | 0.01% | 784 |
|
|
2021
Q3 | $26.5M | Sell |
216,563
-13,314
| -6% | -$1.63M | 0.01% | 800 |
|
|
2021
Q2 | $26.2M | Sell |
229,877
-538
| -0.2% | -$61.3K | 0.01% | 816 |
|
|
2021
Q1 | $27.7M | Sell |
230,415
-18,010
| -7% | -$2.17M | 0.01% | 786 |
|
|
2020
Q4 | $25.2M | Buy |
248,425
+23,658
| +11% | +$2.4M | 0.01% | 786 |
|
|
2020
Q3 | $17.4M | Sell |
224,767
-234
| -0.1% | -$18.1K | 0.01% | 812 |
|
|
2020
Q2 | $25.1M | Buy |
225,001
+65,578
| +41% | +$7.31M | 0.02% | 676 |
|
|
2020
Q1 | $11.5M | Buy |
+159,423
| New | +$11.5M | 0.01% | 822 |
|